1. The University of Kansas
Alzheimer’s Disease Center (KU ADC)
Clinical Research Center | Fairway Office Park
4350 Shawnee Mission Parkway
Fairway, KS 66205
Help us draw the line against
Alzheimer’s Disease
RoeAvenue
The
KU ADC
at the KU
Clinical
Research
Center
How to contact us
913-588-0555
kuamp@kumc.edu | KUAlzheimer.org
KU Alzheimer’s Disease Center
The people of Johnson County, Kansas support space
for the KU ADC through the Johnson County
Education Research Triangle initiative.
Number of National
Institute on Aging
designated and funded
Alzheimer’s Disease Centers
in the United States
*As of February 2016
29*
Different
investigators
supported by the Alzheimer’s
Disease Center who are working
on new approaches to fighting
the disease
100+
Percentage of people
over age 65 who have
Alzheimer’s disease
11%
People over age
85 who have
Alzheimer’s disease
1in 3
Americans living with
Alzheimer’s disease
5 million+
The year we
launched the KU
ADC with an initial grant from
the National Institute on Aging
2011

2. About Us
The University of Kansas Alzheimer’s Disease Center
(KU ADC) is part of a national network of 29* centers
focused on finding a cure for Alzheimer’s disease.
We are the only center with a primary research
focus on the brain’s creation and use of energy, an
important marker of the disease. *As of February 2016
Did you know
• An estimated 5.2 million Americans have
Alzheimer’s disease. There is currently no
proven treatment to prevent, cure or even slow
Alzheimer’s disease.
• By 2025, this number is estimated to increase by
40 percent, affecting 7.1 million people.
• Ninety percent of what is known about
Alzheimer’s disease has been discovered in
the last 15 years. Discoveries like these are
not possible without people volunteering to
participate in research.
• Alzheimer’s disease is one of the top 10 leading
causes of death in America.
Attacking Alzheimer’s through research
The KU Alzheimer’s Disease Center is a National
Institute of Aging-designated and funded
Alzheimer’s Disease Center. Centers with this
elite designation are working to translate research
advances into improved diagnoses and care for
Alzheimer’s disease patients while trying to find
a way to cure and possibly prevent Alzheimer’s
disease. The KU ADC has recruited nationally-
renowned researchers who are now collaborating
with scientists from numerous disciplines on using
state-of-the-art brain imaging techniques to advance
cell metabolism (energy production) research.
How can you help draw the line?
Join a study
By participating in one of our clinical trials, you can
have a direct impact on the fight against Alzheimer’s
disease. We are recruiting adults both with and
without memory problems to help us. Visit our
website KUAlzheimer.org, click on “Join a study,”
and then click “Complete this form” to get started
with the initial screening. Or call 913-588-0555 for
more information.
Donate
Private financial support is critical. There are several
ways to give, including direct donations through
our website at KUalzheimer.org or through KU
Endowment with memorial donations, endowed
funds, expendable funds and planned gifts.
For more information, contact Ted Kimble at
tkimble@kuendowment.org, 3901 Rainbow Blvd.,
MS 3012, Kansas City, KS 66061.
Spread the word
We need you to help us increase awareness of the
KU ADC and our research. Let people know about
us, and help us recruit volunteers. Contact us at
KUamp@kumc.edu or at 913-588-0555 to get more
information.
2003
Namenda receives FDA approval
as Alzheimer’s disease therapy
1991
First gene mutation (APP)
discovered in Alzheimer’s disease
1984
Amyloid discovered (main
marker of Alzheimer’s disease)
1906
Alois Alzheimer reports
study of first patient
2025
Estimated number of people
with Alzheimer’s disease
is expected to increase 40
percent to affect 7.1 million
2011
NIH awarded KU ADC grant and
designated us as one of nationally
recognized Alzheimer’s Disease Center
1997
Aricept receives FDA approval
as Alzheimer’s disease therapy
1987
First clinical trial testing specific
therapy for Alzheimer’s disease
1974
National Institute of Aging
established to better understand the
nature of aging and dementia
1910
The term Alzheimer’s disease
referenced in a medical book
We are drawing the
line to end
Alzheimer’s disease
If we could delay the onset for five years
across the population, we would cut the
prevalence of Alzheimer’s by 50 percent.
Jeff Burns, M.D., co-director, KU Alzheimer’s Disease Center
Jeffrey Burns, M.D.
Russell Swerdlow, M.D., and Heather Wilkins, Ph.D.